News

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...
23andMe to Be Bought by Biotech Company for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...
InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
Pharmaceutical company Regeneron buying 23andMe for $256 million
The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...
Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions
It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...
Rolling Out2d
The fall of 23andMe and what it means for your DNA
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.